Chandelier Retroillumination in a Complex Cataract Extraction

Birkaran Sadhar, and Eric D. Rosenberg, DO, MScEng

Eyetube

Birkaran Sadhar, and Eric D. Rosenberg, DO, MScEng, present a case in which they perform chandelier retroillumination using the Ngenuity 3D Visualization System (Alcon) to extract a complex cataract in the eye of a 75-year-old man with vitreous prolapse.

Beyond DEWS II

An overview of the latest advances in dry eye disease management, treatment innovations, and insights into the condition’s pathophysiology since the landmark TFOS DEWS II report.

Quillan M. Austria, MD, and Christopher E. Starr, MD

Cataract and Refractive Surgery Today

In 2017, the Tear Film and Ocular Surface Society (TFOS) published the TFOS Dry Eye Workshop II (DEWS II) in The Ocular Surface.1-9 The objectives were to update the definition of dry eye disease (DED) established in DEWS I and critically review and integrate the substantial volume of literature on various aspects of DED, including risk factors, pathophysiology, management, and future therapies. Since the publication of DEWS II, the field of DED has grown considerably, with more than 8,000 studies added to the literature. This article highlights some of the significant advances since the publication of DEWS II and seeks to increase awareness of future interventions in DED treatment.

Capturing Geographic Atrophy with Multimodal Imaging

Noninvasive technologies are redefining how we diagnose and monitor atrophic AMD.

Eric H. Souied, MD; Oudy Semoun, MD; and Vittorio Capuano, MD

Retina Today

AT A GLANCE Color fundus photography is often not sufficient for the diagnosis and monitoring of geographic atrophy (GA), and other imaging modalities are needed. OCT and fundus autofluorescence are the standard imaging modalities for the diagnosis of GA. Invasive techniques (ie, fluorescein angiography and ICG angiography) should be reserved for specific cases in which the diagnosis is unclear. OCT angiography may be useful to detect nonexudative macular neovascularization associated with GA. Diagnosis of geographic atrophy (GA) relies on multimodal imaging, including color fundus photography, fundus autofluorescence (FAF) imaging, and structural OCT.1 Diagnosis can be difficult and, at times, may require more invasive tests such as fluorescein angiography (FA) and ICG angiography (ICGA). More recently, OCT angiography (OCTA) has become a useful tool to capture associated choroidal neovascularization as part of mixed GA and wet AMD.2 Here, we discuss noninvasive imaging techniques that can help clinicians establish a definitive diagnosis of GA and follow patients appropriately.